Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO/ARO/AIO-12Emmanouil Fokas, Michael Allgäuer, Bülent Polat et al.|Journal of Clinical Oncology|2019Cited by 536
Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancyOliver Groß, Manfred Weber, Christoph Licht et al.|Kidney International|2011Cited by 361
Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal CancerEmmanouil Fokas, Katica Krajinovic, Anke Schlenska‐Lange et al.|JAMA Oncology|2021Cited by 349
Longitudinal Assessment of Multiple Sclerosis with the Brain‐Age ParadigmJames H. Cole, Joel Raffel, Tim Friede et al.|Annals of Neurology|2020Cited by 158
A multicenter, randomized, placebo-controlled, double-blind phase 3 trial with open-arm comparison indicates safety and efficacy of nephroprotective therapy with ramipril in children with Alport’s syndromeOliver Groß, Markus Feldkoetter, Burkhard Tönshoff et al.|Kidney International|2020Cited by 151